High LncRNA H19 Expression As Prognostic Indicator: Data Mining in Female Cancers and Polling Analysis in Non-female Cancers

Overview

Journal Oncotarget

Specialty Oncology

Date 2016 Dec 8

PMID 27926484

Citations 18

Authors

Li Peng

Xiao-Qing Yuan

Zhao-Yang Liu

Wen-Ling Li

Chao-Yang Zhang

Ya-Qin Zhang

Xi Pan

Jun Chen

Yue-Hui Li

Guan-Cheng Li

Affiliations

Soon will be listed here.

Abstract

Upregulation of lncRNA H19 expression is associated with an unfavorable prognosis in some cancers. However, the prognostic value of H19 in female-specific cancers has remained uncharacterized. In this study, the prognostic power of high H19 expression in female cancer patients from the TCGA datasets was analyzed using Kaplan-Meier survival curves and Cox's proportional hazard modeling. In addition, in a meta-analysis of non-female cancer patients from TCGA datasets and 12 independent studies, hazard ratios (HRs) with 95% confidence interval (CI) for overall survival (OS) and disease-free survival (DFS)/relapse-free survival (RFS)/metastasis-free survival (MFS)/progression-free survival (PFS) were pooled to assess the prognostic value of high H19 expression. Kaplan-Meier analysis revealed that patients with uterine corpus cancer and higher H19 expression had a shorter OS (HR=2.710, p<0.05), while females with cervical cancer and increased H19 expression had a shorter RFS (HR=2.261, p<0.05). Multivariate Cox regression analysis showed that high H19 expression could independently predict a poorer prognosis in cervical cancer patients (HR=4.099, p<0.05). In the meta-analysis, patients with high H19 expression showed a poorer outcome in non-female cancer (p<0.05). These results suggest that high lncRNA H19 expression is predictive of an unfavorable prognosis in two female cancers (uterine corpus endometrioid cancer and cervical cancer) as well as in non-female cancer patients.

Citing Articles

The emerging roles of long non-coding RNA (lncRNA) H19 in gynecologic cancers.

Ghasemian M, Zehtabi M, Gale Dari M, Pour F, Azizi Tabesh G, Moramezi F BMC Cancer. 2024; 24(1):4.

PMID: 38166752 PMC: 10763168. DOI: 10.1186/s12885-023-11743-z.

The role of long non-coding RNA H19 in infertility.

Peng Y, Guo R, Shi B, Li D Cell Death Discov. 2023; 9(1):268.

PMID: 37507391 PMC: 10382492. DOI: 10.1038/s41420-023-01567-y.

The role of long noncoding RNA H19 in gynecological pathologies: Insights into gene regulation and immune modulation (Review).

Xin W, Wang Y, Hua K, Liu S Int J Mol Med. 2023; 52(2).

PMID: 37449492 PMC: 10373120. DOI: 10.3892/ijmm.2023.5276.

Long noncoding RNA H19 regulates degeneration and regeneration of injured peripheral nerves.

Feng Y, Shao J, Cai M, Zhou Y, Yao Y, Qian J Neural Regen Res. 2023; 18(8):1847-1851.

PMID: 36751815 PMC: 10154483. DOI: 10.4103/1673-5374.363182.

Predicting recurrence and metastasis risk of endometrial carcinoma prognostic signatures identified from multi-omics data.

Li L, Qiu W, Lin L, Liu J, Shi X, Shi Y Front Oncol. 2022; 12:982452.

PMID: 36059678 PMC: 9438970. DOI: 10.3389/fonc.2022.982452.

References

Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M . Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2014; 136(5):E359-86. DOI: 10.1002/ijc.29210. View

Allemani C, Weir H, Carreira H, Harewood R, Spika D, Wang X . Global surveillance of cancer survival 1995-2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2). Lancet. 2014; 385(9972):977-1010. PMC: 4588097. DOI: 10.1016/S0140-6736(14)62038-9. View

Liang W, Fu W, Wong C, Wang Y, Wang W, Hu G . The lncRNA H19 promotes epithelial to mesenchymal transition by functioning as miRNA sponges in colorectal cancer. Oncotarget. 2015; 6(26):22513-25. PMC: 4673179. DOI: 10.18632/oncotarget.4154. View

Li C, Chen J, Zhang K, Feng B, Wang R, Chen L . Progress and Prospects of Long Noncoding RNAs (lncRNAs) in Hepatocellular Carcinoma. Cell Physiol Biochem. 2015; 36(2):423-34. DOI: 10.1159/000430109. View

Xia Z, Yan R, Duan F, Song C, Wang P, Wang K . Genetic Polymorphisms in Long Noncoding RNA H19 Are Associated With Susceptibility to Breast Cancer in Chinese Population. Medicine (Baltimore). 2016; 95(7):e2771. PMC: 4998624. DOI: 10.1097/MD.0000000000002771. View

Kanduri C . Long noncoding RNAs: Lessons from genomic imprinting. Biochim Biophys Acta. 2015; 1859(1):102-11. DOI: 10.1016/j.bbagrm.2015.05.006. View

Tierney J, Stewart L, Ghersi D, Burdett S, Sydes M . Practical methods for incorporating summary time-to-event data into meta-analysis. Trials. 2007; 8:16. PMC: 1920534. DOI: 10.1186/1745-6215-8-16. View

Fellig Y, Ariel I, Ohana P, Schachter P, Sinelnikov I, Birman T . H19 expression in hepatic metastases from a range of human carcinomas. J Clin Pathol. 2005; 58(10):1064-8. PMC: 1770739. DOI: 10.1136/jcp.2004.023648. View

Chen J, Wang Y, Zhang X, Lv J, Li Y, Liu X . H19 serves as a diagnostic biomarker and up-regulation of H19 expression contributes to poor prognosis in patients with gastric cancer. Neoplasma. 2016; 63(2):223-30. DOI: 10.4149/207_150821N454. View

10.

Zou T, Jaladanki S, Liu L, Xiao L, Chung H, Wang J . H19 Long Noncoding RNA Regulates Intestinal Epithelial Barrier Function via MicroRNA 675 by Interacting with RNA-Binding Protein HuR. Mol Cell Biol. 2016; 36(9):1332-41. PMC: 4836219. DOI: 10.1128/MCB.01030-15. View

11.

Jia P, Cai H, Liu X, Chen J, Ma J, Wang P . Long non-coding RNA H19 regulates glioma angiogenesis and the biological behavior of glioma-associated endothelial cells by inhibiting microRNA-29a. Cancer Lett. 2016; 381(2):359-69. DOI: 10.1016/j.canlet.2016.08.009. View

12.

Parmar M, Torri V, Stewart L . Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med. 1999; 17(24):2815-34. DOI: 10.1002/(sici)1097-0258(19981230)17:24<2815::aid-sim110>3.0.co;2-8. View

13.

Di Gesualdo F, Capaccioli S, Lulli M . A pathophysiological view of the long non-coding RNA world. Oncotarget. 2014; 5(22):10976-96. PMC: 4294373. DOI: 10.18632/oncotarget.2770. View

14.

Liu L, Yang J, Zhu X, Li D, Lv Z, Zhang X . Long noncoding RNA H19 competitively binds miR-17-5p to regulate YES1 expression in thyroid cancer. FEBS J. 2016; 283(12):2326-39. DOI: 10.1111/febs.13741. View

15.

Han D, Gao X, Wang M, Qiao Y, Xu Y, Yang J . Long noncoding RNA H19 indicates a poor prognosis of colorectal cancer and promotes tumor growth by recruiting and binding to eIF4A3. Oncotarget. 2016; 7(16):22159-73. PMC: 5008352. DOI: 10.18632/oncotarget.8063. View

16.

Yuan X, Zhang D, Yan H, Yang Y, Zhu K, Chen Y . Evaluation of DNMT3A genetic polymorphisms as outcome predictors in AML patients. Oncotarget. 2016; 7(37):60555-60574. PMC: 5312402. DOI: 10.18632/oncotarget.11143. View

17.

Rachon D . Endocrine disrupting chemicals (EDCs) and female cancer: Informing the patients. Rev Endocr Metab Disord. 2016; 16(4):359-64. PMC: 4801991. DOI: 10.1007/s11154-016-9332-9. View

18.

Zeira E, Abramovitch R, Meir K, Even Ram S, Gil Y, Bulvik B . The knockdown of H19lncRNA reveals its regulatory role in pluripotency and tumorigenesis of human embryonic carcinoma cells. Oncotarget. 2015; 6(33):34691-703. PMC: 4741483. DOI: 10.18632/oncotarget.5787. View

19.

Zhang E, Han L, Yin D, Kong R, De W, Chen J . c-Myc-induced, long, noncoding H19 affects cell proliferation and predicts a poor prognosis in patients with gastric cancer. Med Oncol. 2014; 31(5):914. DOI: 10.1007/s12032-014-0914-7. View

20.

Lu X, Wan F, Zhang H, Shi G, Ye D . ITGA2B and ITGA8 are predictive of prognosis in clear cell renal cell carcinoma patients. Tumour Biol. 2015; 37(1):253-62. DOI: 10.1007/s13277-015-3792-5. View